Gene: TXLNA
Official Full Name: taxilin alphaprovided by HGNC
Gene Summary: Predicted to enable syntaxin binding activity. Predicted to be involved in exocytosis. Predicted to act upstream of or within B cell activation. Located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO38370 | TXLNA Knockout cell line (HeLa) | Human | TXLNA | 1:3~1:6 | Negative | Online Inquiry |
KO38371 | TXLNA Knockout cell line (HCT 116) | Human | TXLNA | 1:2~1:4 | Negative | Online Inquiry |
KO38372 | TXLNA Knockout cell line (HEK293) | Human | TXLNA | 1:3~1:6 | Negative | Online Inquiry |
KO38373 | TXLNA Knockout cell line (A549) | Human | TXLNA | 1:3~1:4 | Negative | Online Inquiry |
TXLNA Gene Knockout Cell Lines are specialized cellular models created through advanced gene-editing techniques to selectively disrupt the TXLNA gene. This innovative product enables researchers to study the biological impacts of TXLNA loss-of-function in various contexts, facilitating an in-depth understanding of its role in cellular processes such as proliferation, differentiation, and response to external stimuli. The knockout mechanism is typically achieved via CRISPR-Cas9 technology, ensuring precise and efficient genomic editing.
The primary function of TXLNA gene knockout cell lines is to provide a valuable tool for investigating the functional consequences of TXLNA deficiency. These cell lines can reveal insights into cellular signaling pathways, metabolic changes, and stress responses attributable to the absence of TXLNA, contributing to the broader understanding of related pathological conditions, including cancer and neurodegenerative diseases. In clinical settings, these cell lines can be utilized to screen potential therapeutic compounds targeting the pathways influenced by TXLNA, providing a crucial bridge between basic research and therapeutics.
One of the key advantages of our TXLNA Gene Knockout Cell Lines is their superior reliability and reproducibility compared to alternative models, such as transient transfected cells or other established knockout models that may have variable backgrounds. Furthermore, these cell lines are offered in various background strains, allowing researchers the flexibility to choose a starting point that best suits their experimental needs. The ability to maintain consistent results across different laboratories enhances the product's utility.
Researchers and clinicians will find TXLNA Gene Knockout Cell Lines indispensable for elucidating the role of TXLNA in cellular physiology and pathology. This comprehensive understanding can drive the development of targeted therapies and improve diagnostic accuracy. Our commitment to quality assurance and cutting-edge scientific methodologies underscores our expertise in providing top-tier biological products, ensuring that researchers have access to the tools they need to advance their work effectively.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.